You are here

Article Text

Article menu

Download PDFPDF

Research letter
EBUS-guided mediastinal lung cancer staging: monitoring of quality standards improves performance
Free
  1. Matthew Evison1,2,
  2. Philip Crosbie1,2,
  3. Julie Martin1,
  4. Rajesh Shah3,
  5. Helen Doran4,
  6. Zoe Borrill5,
  7. Jennifer Hoyle5,
  8. Durgesh Rana6,
  9. Simon Bailey7,
  10. Richard Booton1,2
  1. 1Manchester Thoracic Oncology Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK
  2. 2The Institute of Inflammation and Repair, The University of Manchester, Manchester, UK
  3. 3Department of Thoracic Surgery, University Hospital South Manchester, Manchester, UK
  4. 4Department of Pathology, University Hospital South Manchester, Manchester, UK
  5. 5Department of Respiratory Medicine, North Manchester General Hospital, Pennine Acute NHS Trusts, Manchester, UK
  6. 6Department of Cytopathology, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
  7. 7Department of Respiratory Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
  1. Correspondence to Dr Matthew Evison, Manchester Thoracic Oncology Centre, University Hospital of South Manchester, Southmoor Road, Wythenshawe M23 9LT, UK; m.evison{at}nhs.net, matthew.evison{at}uhsm.nhs.uk

Abstract

This audit examined key performance indices related to endobronchial ultrasound (EBUS)-guided mediastinal lung cancer staging before and after the introduction of defined quality standards, at four independent EBUS centres in one cancer network. Data from 642 procedures were prospectively collected and analysed. The introduction of standards was associated with a significant increase (p<0.001) in sampling of key mediastinal lymph node stations (4R, 4L and 7) and a reduction in the variability of staging sensitivity between centres. These data reinforce the requirement for an appropriate regulatory framework for EBUS-transbronchial needle aspiration provision that includes quality assurance and performance monitoring.

  • Bronchoscopy
  • Lung Cancer
  • Non-Small Cell Lung Cancer
  • Thoracic Surgery

https://doi.org/10.1136/thoraxjnl-2015-206985

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text